Erythropoietin

Dr. Litwack was formerly Professor of Molecular and Cellular Medicine and Associate Director at the Institute for Regenerative Medicine, Texas A & M Health Science Center.

1. Erythropoietin Receptor Structural Domains Qingxin Li and CongBao Kang 2. Analysis of the Asymmetry of Activated EPO Receptor Enables Designing Small Molecule Agonists Frank Guarnieri 3. Endogenous Erythropoietin Steven J. Korzeniewski and Athina Pappas 4. Erythropoietin Regulation by Angiotensin II Yong-Chul Kim, Ognoon Mungunsukh and Regina M. Day 5. Erythropoietin Receptor Signaling and Lipid Rafts Kathy McGraw and Alan List 6. Erythropoietin and Hypothalamic-Pituitary Axis Soumyadeep Dey and Constance T. Noguchi 7 Erythropoietin-Mediated Regulation of Central Respiratory Command Tommy Seaborn and Céline Caravagna 8. Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis Ilona Rybinska and Gaetano Cairo 9. Context-Dependent Skeletal Effects of Erythropoietin Sahar Hiram-Bab, Drorit Neumann and Yankel Gabet 10. Erythropoietin-Mediated Neuroprotection in Insects Suggests a Prevertebrate Evolution of Erythropoietin-Like Signaling Ralf Heinrich, Verena Günther and Natasa Miljus 11. Erythropoietin: Endogenous Protection of Ischemic Brain Robert T. Mallet and Myoung-Gwi Ryou 12. The Erythropoietin System Protects the Heart Upon Injury by Cardiac Progenitor Cell Activation Maria P. Zafeiriou 13. Erythropoietin Promotes Glioblastoma via miR-451 Suppression Begum Alural, Zeynep O. Ayyildiz, Kemal U. Tufekci, Sermin Genc and Kursad Genc 14. Erythropoietin, Stem Cell Factor, and Cancer Cell Migration Maria J. Vazquez-Mellado, Victor M. Embriz and Leticia Rocha-Zavaleta 15. Significance of Erythropoietin Receptor Antagonist EMP9 in Cancers Yoshiko Yasuda and Mitsugu Fujita